gene therapy

News

Submission completed, Spark sets sight on first ever US gene...

Spark Therapeutics has completed the rolling submission of gene therapy product voretigene neparvovec, for patients with a rare genetic form of blindness.

News

Sangamo and new gene therapy partner Pfizer lifted by FDA fa...

Sangamo Therapeutics has been granted a fast track designation from the FDA for SB-525, its gene therapy candidate for haemophilia A.

News

Red blood cells moving in blood vessels with depth of field.

Spark and Pfizer's haemophilia gene therapy gets European PR...

Decision based on promising data from ongoing phase 1/2 trial.

Events

Partner Content

2nd Annual Bioprocessing of Advanced Cellular Therapies Cong...

After the success of the previous edition - Bioprocessing of Advanced Cellular Therapies Congress 2016

News

Gene therapy for hearts gets FDA fast track

Angionetics claims place among leaders in cardiovascular angiogenic gene therapy.

News

Spark reassures on safety of haemophilia gene therapy

Study of nine patients produce encouraging results

Submission completed, Spark sets sight on first ever US gene...

Sangamo and new gene therapy partner Pfizer lifted by FDA fa...

Spark and Pfizer's haemophilia gene therapy gets European PR...

2nd Annual Bioprocessing of Advanced Cellular Therapies Cong...

Gene therapy for hearts gets FDA fast track

Spark reassures on safety of haemophilia gene therapy

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

gene therapy

Editor's Picks